Katie Dougherty, DO
Family Medicine · Philadelphia, PANPI 1962433649
Payments from drug & device makers
Across 32 payments — averaging $19.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$369
- Amarin Pharma, Inc.$146
- Lilly USA, LLC$60
- Idorsia Pharmaceuticals US Inc$21
- Johnson & Johnson$17
What the payments were for
- Food & beverage$612100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 19 | $369 |
| Amarin Pharma, Inc. | 8 | $146 |
| Lilly USA, LLC | 3 | $60 |
| Idorsia Pharmaceuticals US Inc | 1 | $21 |
| Johnson & Johnson | 1 | $17 |
How this compares
$612 in reported general payments places this provider in the 60th percentile of 4,967 family medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 31 | $27,745 |
| OzempicSemaglutide | 21 | $26,458 |
| Atorvastatin Calcium | 280 | $5,013 |
| Levothyroxine Sodium | 232 | $3,999 |
| Rosuvastatin Calcium | 164 | $3,783 |
| Losartan Potassium | 178 | $3,368 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 123 | $2,851 |
| Metoprolol Succinate | 132 | $2,592 |
| Omega-3 Acid Ethyl Esters | 22 | $2,310 |
| Solifenacin Succinate | 12 | $2,252 |
| Gabapentin | 131 | $1,927 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 16 | $1,772 |
| Lidocaine | 12 | $1,758 |
| Escitalopram Oxalate | 110 | $1,684 |
| Nebivolol Hcl | 28 | $1,525 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Philadelphia
- Daniel LinPhiladelphia$392K
- Glenn RosenPhiladelphia$367K
- Christopher ChambersPhiladelphia$350K
- Deborah WittPhiladelphia$226K
- Michael AttanasioPhiladelphia$214K
- Jonah MinkPhiladelphia$145K
- Celia EzidiegwuPhiladelphia$118K
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.